{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:34:50Z","timestamp":1740123290129,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Be Brave for Life"},{"name":"Kids@Heart Fund"},{"name":"Chae Fund"},{"name":"Irving Fund"},{"name":"Lucas Warner Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10571-023-01447-0","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T09:02:36Z","timestamp":1703667756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-6430","authenticated-orcid":false,"given":"Julie","family":"Sesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-5814","authenticated-orcid":false,"given":"Aram","family":"Ghalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-0051","authenticated-orcid":false,"given":"Jessica","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-3620","authenticated-orcid":false,"given":"Tyra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-0169","authenticated-orcid":false,"given":"Adrien","family":"Lupieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-6942","authenticated-orcid":false,"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-4184","authenticated-orcid":false,"given":"Sanda","family":"Alexandrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-8450","authenticated-orcid":false,"given":"Edward R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-0931","authenticated-orcid":false,"given":"Katie P.","family":"Fehnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"issue":"19","key":"1447_CR1","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1182\/blood-2011-09-380006","volume":"119","author":"MA Abengozar","year":"2012","unstructured":"Abengozar MA, de Frutos S, Ferreiro S, Soriano J, Perez-Martinez M, Olmeda D, Marenchino M, Canamero M, Ortega S, Megias D, Rodriguez A, Martinez-Torrecuadrada JL (2012) Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood 119(19):4565\u20134576. https:\/\/doi.org\/10.1182\/blood-2011-09-380006","journal-title":"Blood"},{"issue":"14","key":"1447_CR2","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-13-3116","volume":"74","author":"T Akino","year":"2014","unstructured":"Akino T, Han X, Nakayama H, McNeish B, Zurakowski D, Mammoto A, Klagsbrun M, Smith E (2014) Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Can Res 74(14):3716\u20133726. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3116","journal-title":"Can Res"},{"issue":"3","key":"1447_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4067\/S0716-97602009000300012","volume":"42","author":"E Aranda","year":"2009","unstructured":"Aranda E, Owen GI (2009) A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol Res 42(3):377\u2013389","journal-title":"Biol Res"},{"issue":"2","key":"1447_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.str.2005.11.011","volume":"14","author":"JE Chrencik","year":"2006","unstructured":"Chrencik JE, Brooun A, Recht MI, Kraus ML, Koolpe M, Kolatkar AR, Bruce RH, Martiny-Baron G, Widmer H, Pasquale EB, Kuhn P (2006) Structure and thermodynamic characterization of the EphB4\/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. Structure 14(2):321\u2013330. https:\/\/doi.org\/10.1016\/j.str.2005.11.011","journal-title":"Structure"},{"issue":"4","key":"1447_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3171\/2017.9.PEDS17365","volume":"21","author":"D Duran","year":"2018","unstructured":"Duran D, Karschnia P, Gaillard JR, Karimy JK, Youngblood MW, DiLuna ML, Matouk CC, Aagaard-Kienitz B, Smith ER, Orbach DB, Rodesch G, Berenstein A, Gunel M, Kahle KT (2018) Human genetics and molecular mechanisms of vein of Galen malformation. J Neurosurg Pediatr 21(4):367\u2013374. https:\/\/doi.org\/10.3171\/2017.9.PEDS17365","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"1447_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neuron.2018.11.041","volume":"101","author":"D Duran","year":"2019","unstructured":"Duran D, Zeng X, Jin SC, Choi J, Nelson-Williams C, Yatsula B, Gaillard J, Furey CG, Lu Q, Timberlake AT, Dong W, Sorscher MA, Loring E, Klein J, Allocco A, Hunt A, Conine S, Karimy JK, Youngblood MW, Zhang J, DiLuna ML, Matouk CC, Mane S, Tikhonova IR, Castaldi C, Lopez-Giraldez F, Knight J, Haider S, Soban M, Alper SL, Komiyama M, Ducruet AF, Zabramski JM, Dardik A, Walcott BP, Stapleton CJ, Aagaard-Kienitz B, Rodesch G, Jackson E, Smith ER, Orbach DB, Berenstein A, Bilguvar K, Vikkula M, Gunel M, Lifton RP, Kahle KT (2019) Mutations in chromatin modifier and ephrin signaling genes in vein of galen malformation. Neuron 101(3):429-443 e424. https:\/\/doi.org\/10.1016\/j.neuron.2018.11.041","journal-title":"Neuron"},{"issue":"5","key":"1447_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tcb.2007.03.004","volume":"17","author":"J Egea","year":"2007","unstructured":"Egea J, Klein R (2007) Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol 17(5):230\u2013238. https:\/\/doi.org\/10.1016\/j.tcb.2007.03.004","journal-title":"Trends Cell Biol"},{"issue":"4","key":"1447_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s12276-020-0414-0","volume":"52","author":"KP Fehnel","year":"2020","unstructured":"Fehnel KP, Penn DL, Duggins-Warf M, Gruber M, Pineda S, Sesen J, Moses-Gardner A, Shah N, Driscoll J, Zurakowski D, Orbach DB, Smith ER (2020) Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients. Exp Mol Med 52(4):658\u2013671. https:\/\/doi.org\/10.1038\/s12276-020-0414-0","journal-title":"Exp Mol Med"},{"issue":"1","key":"1447_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/01.neu.0000440729.59133.c9","volume":"55","author":"J Gault","year":"2004","unstructured":"Gault J, Sarin H, Awadallah NA, Shenkar R, Awad IA (2004) Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 55(1):1\u201316","journal-title":"Neurosurgery"},{"issue":"12","key":"1447_CR10","doi-asserted-by":"publisher","first-page":"e0226852","DOI":"10.1371\/journal.pone.0226852","volume":"14","author":"JA Goss","year":"2019","unstructured":"Goss JA, Huang AY, Smith E, Konczyk DJ, Smits PJ, Sudduth CL, Stapleton C, Patel A, Alexandrescu S, Warman ML, Greene AK (2019) Somatic mutations in intracranial arteriovenous malformations. PLoS ONE 14(12):e0226852. https:\/\/doi.org\/10.1371\/journal.pone.0226852","journal-title":"PLoS ONE"},{"issue":"6","key":"1447_CR11","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.3171\/2011.3.FOCUS1165","volume":"30","author":"BA Gross","year":"2011","unstructured":"Gross BA, Lin N, Du R, Day AL (2011) The natural history of intracranial cavernous malformations. Neurosurg Focus 30(6):E24","journal-title":"Neurosurg Focus"},{"issue":"5","key":"1447_CR12","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1227\/01.NEU.0000180811.56157.E1","volume":"57","author":"B Guclu","year":"2005","unstructured":"Guclu B, Ozturk AK, Pricola KL, Bilguvar K, Shin D, O\u2019Roak BJ, Gunel M (2005) Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery 57(5):1008\u20131013","journal-title":"Neurosurgery"},{"issue":"2","key":"1447_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ejhg.2011.155","volume":"20","author":"RA Haasdijk","year":"2012","unstructured":"Haasdijk RA, Cheng C, Maat-Kievit AJ, Duckers HJ (2012) Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management. Eur J Hum Genet 20(2):134\u2013140","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1447_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/stem.1841","volume":"33","author":"L Huang","year":"2015","unstructured":"Huang L, Nakayama H, Klagsbrun M, Mulliken JB, Bischoff J (2015) Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells 33(1):133\u2013145. https:\/\/doi.org\/10.1002\/stem.1841","journal-title":"Stem Cells"},{"key":"1447_CR15","doi-asserted-by":"publisher","DOI":"10.3171\/2022.12.PEDS22332","author":"KT Kahle","year":"2023","unstructured":"Kahle KT, Duran D, Smith ER (2023) Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics. J Neurosurg Pediatr. https:\/\/doi.org\/10.3171\/2022.12.PEDS22332","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"1447_CR16","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1172\/JCI67084","volume":"124","author":"J Kawasaki","year":"2014","unstructured":"Kawasaki J, Aegerter S, Fevurly RD, Mammoto A, Mammoto T, Sahin M, Mably JD, Fishman SJ, Chan J (2014) RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity. J Clin Invest 124(6):2774\u20132784. https:\/\/doi.org\/10.1172\/JCI67084","journal-title":"J Clin Invest"},{"issue":"3","key":"1447_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3892\/ijmm.2014.1818","volume":"34","author":"J Liu","year":"2014","unstructured":"Liu J, Dong F, Jeong J, Masuda T, Lobe CG (2014) Constitutively active Notch1 signaling promotes endothelial-mesenchymal transition in a conditional transgenic mouse model. Int J Mol Med 34(3):669\u2013676","journal-title":"Int J Mol Med"},{"issue":"7455","key":"1447_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, Tournier-Lasserve E, Chapon F, Richichi C, Retta SF, Lampugnani MG, Dejana E (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498(7455):492\u2013496. https:\/\/doi.org\/10.1038\/nature12207","journal-title":"Nature"},{"issue":"2","key":"1447_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000512800","volume":"50","author":"K Peterson","year":"2021","unstructured":"Peterson K, Coffman S, Zehri A, Anzalone A, Xiang Z, Wolfe S (2021) Somatic mosaicism in the pathogenesis of de novo cerebral arteriovenous malformations: a paradigm shift implicating the RAS-MAPK signaling cascade. Cerebrovasc Dis 50(2):231\u2013238. https:\/\/doi.org\/10.1159\/000512800","journal-title":"Cerebrovasc Dis"},{"key":"1447_CR20","doi-asserted-by":"publisher","DOI":"10.3171\/2015.12.PEDS15448","author":"K Pricola Fehnel","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, Zurakowski D, McKee-Proctor M, Majumder R, Raber M, Han X, Smith ER (2016) Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Pediatr. https:\/\/doi.org\/10.3171\/2015.12.PEDS15448","journal-title":"J Neurosurg Pediatr"},{"issue":"7862","key":"1447_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, Snellings DA, Su YS, Hong CC, Castro M, Tang AT, Detter MR, Hobson N, Girard R, Romanos S, Lightle R, Moore T, Shenkar R, Benavides C, Beaman MM, Muller-Fielitz H, Chen M, Mericko P, Yang J, Sung DC, Lawton MT, Ruppert JM, Schwaninger M, Korbelin J, Potente M, Awad IA, Marchuk DA, Kahn ML (2021) PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594(7862):271\u2013276. https:\/\/doi.org\/10.1038\/s41586-021-03562-8","journal-title":"Nature"},{"issue":"9","key":"1447_CR22","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1093\/brain\/awad104","volume":"146","author":"J Ren","year":"2023","unstructured":"Ren J, Huang Y, Ren Y, Tu T, Qiu B, Ai D, Bi Z, Bai X, Li F, Li JL, Chen XJ, Feng Z, Guo Z, Lei J, Tian A, Cui Z, Lindner V, Adams RH, Wang Y, Zhao F, Korbelin J, Sun W, Wang Y, Zhang H, Hong T, Ge WP (2023) Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations. Brain 146(9):3634\u20133647. https:\/\/doi.org\/10.1093\/brain\/awad104","journal-title":"Brain"},{"issue":"2","key":"1447_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.STR.0000198835.49387.25","volume":"37","author":"A Seker","year":"2006","unstructured":"Seker A, Pricola KL, Guclu B, Ozturk AK, Louvi A, Gunel M (2006) CCM2 expression parallels that of CCM1. Stroke 37(2):518\u2013523","journal-title":"Stroke"},{"key":"1447_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s44161-022-00035-7","volume":"1","author":"DA Snellings","year":"2022","unstructured":"Snellings DA, Girard R, Lightle R, Srinath A, Romanos S, Li Y, Chen C, Ren AA, Kahn ML, Awad IA, Marchuk DA (2022) Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat Cardiovasc Res 1:246\u2013252. https:\/\/doi.org\/10.1038\/s44161-022-00035-7","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"1447_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/neuros\/nyx078","volume":"81","author":"S Takada","year":"2017","unstructured":"Takada S, Hojo M, Tanigaki K, Miyamoto S (2017) Contribution of endothelial-to-mesenchymal transition to the pathogenesis of human cerebral and orbital cavernous malformations. Neurosurgery 81(1):176\u2013183. https:\/\/doi.org\/10.1093\/neuros\/nyx078","journal-title":"Neurosurgery"},{"issue":"4","key":"1447_CR26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1227\/01.neu.0000318179.02912.ca","volume":"62","author":"G Tanriover","year":"2008","unstructured":"Tanriover G, Boylan AJ, Diluna ML, Pricola KL, Louvi A, Gunel M (2008) PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit. Neurosurgery 62(4):930\u2013938","journal-title":"Neurosurgery"},{"issue":"5","key":"1447_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40257-020-00528-w","volume":"21","author":"A Van Damme","year":"2020","unstructured":"Van Damme A, Seront E, Dekeuleneer V, Boon LM, Vikkula M (2020) New and emerging targeted therapies for vascular malformations. Am J Clin Dermatol 21(5):657\u2013668. https:\/\/doi.org\/10.1007\/s40257-020-00528-w","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"1447_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2021.04.005","volume":"108","author":"J Weng","year":"2021","unstructured":"Weng J, Yang Y, Song D, Huo R, Li H, Chen Y, Nam Y, Zhou Q, Jiao Y, Fu W, Yan Z, Wang J, Xu H, Di L, Li J, Wang S, Zhao J, Wang J, Cao Y (2021) Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. Am J Hum Genet 108(5):942\u2013950. https:\/\/doi.org\/10.1016\/j.ajhg.2021.04.005","journal-title":"Am J Hum Genet"},{"issue":"9","key":"1447_CR29","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/jcmm.13105","volume":"21","author":"C You","year":"2017","unstructured":"You C, Zhao K, Dammann P, Keyvani K, Kreitschmann-Andermahr I, Sure U, Zhu Y (2017) EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation. J Cell Mol Med 21(9):1848\u20131858. https:\/\/doi.org\/10.1111\/jcmm.13105","journal-title":"J Cell Mol Med"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-023-01447-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T11:06:43Z","timestamp":1734174403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-023-01447-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s10571-023-01447-0","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"type":"print","value":"0272-4340"},{"type":"electronic","value":"1573-6830"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Boston Children\u2019s Hospital IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"12"}}